Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02377843 · ClinicalTrials.gov registry record · NA

Making Effective Human Papillomavirus (HPV) Vaccine Recommendations

A NA study, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT02377843 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02377843, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

Coverage of HPV vaccination among US teens is low, far below Healthy People 2020 goals. A central reason for low coverage is infrequent and inadequate healthcare provider recommendation of HPV vaccine. The proposed intervention aims to train clinicians to provide effective recommendations for the vaccine using participatory or efficient communication strategies. This study will evaluate the effectiveness of two communication trainings to increase HPV vaccination coverage among adolescent patients. We will compare HPV vaccination for pediatric and family medicine clinics receiving a participatory communication training, efficient communication training, or no training. Ten clinics will be randomly assigned to each study arm for a total of 30 clinics. The primary outcome of this study is to compare the change in clinics' levels of HPV vaccination initiation coverage among 11-12 year old adolescent patients from baseline to 6 month follow-up. Secondarily, we will compare the change in HPV vaccination initiation coverage in 13-17 year old adolescents.

Interventions

  • BEHAVIORAL Participatory
  • BEHAVIORAL Efficient

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2015-03
Est. Completion 2016-03
Phase NA

What the Registry Record Tells You About NCT02377843

The ClinicalTrials.gov registry entry for NCT02377843 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Participatory is the first listed.

NCT02377843 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02377843 about?

NCT02377843 is a clinical study titled "Making Effective Human Papillomavirus (HPV) Vaccine Recommendations". Coverage of HPV vaccination among US teens is low, far below Healthy People 2020 goals. A central reason for low coverage is infrequent and inadequate healthcare provider recommendation of HPV vaccine. The proposed intervention aims to train clinicians to provide effective recommendations for the va...

What is the current status of trial NCT02377843?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2015-03. Estimated completion is 2016-03.

What interventions are being tested in trial NCT02377843?

The interventions under investigation include: Participatory (BEHAVIORAL), Efficient (BEHAVIORAL).

Who is sponsoring clinical trial NCT02377843?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.